These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4157329)

  • 41. Dopaminergic drug-receptor interactions.
    Scott JE
    Trends Pharmacol Sci; 1989 Jan; 10(1):14-5. PubMed ID: 2574508
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of prior administration of aminophylline, caffeine, or propranolol on the antitumor activity of 6-mercaptopurine or 6-mercaptopurine riboside.
    Sasaki K; Furusawa S; Takayanagi G
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):276-9. PubMed ID: 7196294
    [No Abstract]   [Full Text] [Related]  

  • 43. Methylxanthine-facilitated shock-induced aggression in the rat.
    Eichelman B; Orenberg E; Hackley P; Barchas J
    Psychopharmacology (Berl); 1978 Apr; 56(3):305-8. PubMed ID: 418439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of caffeine and aminophylline on adult development of the Cecropia silkmoth.
    McDaniel CN; Berry SJ
    J Insect Physiol; 1974 Feb; 20(2):245-52. PubMed ID: 4815634
    [No Abstract]   [Full Text] [Related]  

  • 45. Peripheral dopaminergic nerves.
    Bell C
    Pharmacol Ther; 1989; 44(2):157-79. PubMed ID: 2577510
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuropharmacological actions of enkephalin after systemic administration.
    Plotnikoff NP; Kastin AJ; Coy DH; Christensen CW; Schally AV; Spirtes MA
    Life Sci; 1976 Oct; 19(8):1283-8. PubMed ID: 186682
    [No Abstract]   [Full Text] [Related]  

  • 47. [Action of 3,4-dihydroxyphenylanine (DOPA) of dopamine and adrenalin on myosis of sleep].
    MANTEGAZZINI P; FERRARA GB
    Arch Ital Sci Farmacol; 1960 Jul; 10():284-8. PubMed ID: 13766312
    [No Abstract]   [Full Text] [Related]  

  • 48. Preliminary study of caffeine and chloroquine enhancement of x-ray induced birth defects.
    Yielding LW; Riley TL; Yielding KL
    Biochem Biophys Res Commun; 1976 Feb; 68(4):1356-61. PubMed ID: 1267783
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson's Disease.
    de Moraes Santos Corrêa É; Christofoletti G; de Souza AS
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular and Locomotor Effects of Binary Mixtures of Common "Bath Salts" Constituents: Studies with Methylone, MDPV, and Caffeine in Rats.
    Seaman RW; Galindo DG; Stinson BT; Sulima A; Rice KC; Javors MA; Ginsburg BC; Collins GT
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.
    Wong TS; Li G; Li S; Gao W; Chen G; Gan S; Zhang M; Li H; Wu S; Du Y
    Signal Transduct Target Ther; 2023 May; 8(1):177. PubMed ID: 37137892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mGlu
    Romero-Fernandez W; Taura JJ; Crans RAJ; Lopez-Cano M; Fores-Pons R; Narváez M; Carlsson J; Ciruela F; Fuxe K; Borroto-Escuela DO
    Mol Neurobiol; 2022 Oct; 59(10):5955-5969. PubMed ID: 35829830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric Interactions between Adenosine A
    Prasad K; de Vries EFJ; Elsinga PH; Dierckx RAJO; van Waarde A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A2AR Transmembrane 2 Peptide Administration Disrupts the A2AR-A2AR Homoreceptor but Not the A2AR-D2R Heteroreceptor Complex: Lack of Actions on Rodent Cocaine Self-Administration.
    Borroto-Escuela DO; Wydra K; Romero-Fernandez W; Zhou Z; Frankowska M; Filip M; Fuxe K
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.
    Tóth A; Antal Z; Bereczki D; Sperlágh B
    Neurochem Res; 2019 Oct; 44(10):2413-2422. PubMed ID: 31054067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Craving espresso: the dialetics in classifying caffeine as an abuse drug.
    Dos Santos MKF; Gavioli EC; Rosa LS; de Paula Soares-Rachetti V; Lobão-Soares B
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1301-1318. PubMed ID: 30338342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors.
    Borroto-Escuela DO; Perez De La Mora M; Manger P; Narváez M; Beggiato S; Crespo-Ramírez M; Navarro G; Wydra K; Díaz-Cabiale Z; Rivera A; Ferraro L; Tanganelli S; Filip M; Franco R; Fuxe K
    Front Synaptic Neurosci; 2018; 10():20. PubMed ID: 30042672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A
    Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D
    Front Pharmacol; 2018; 9():243. PubMed ID: 29686613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.
    Ferré S
    Psychopharmacology (Berl); 2016 May; 233(10):1963-79. PubMed ID: 26786412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.
    Chen X; Ghribi O; Geiger JD
    J Alzheimers Dis; 2010; 20 Suppl 1(Suppl 1):S127-41. PubMed ID: 20164568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.